Understanding how certain factors influence lung cancer development
Investigating molecular regulators of a mixed-lineage state in lung adenocarcinoma
This study is looking at how certain proteins in lung cancer cells work together and change to help the cancer grow, with the hope that this information can lead to new treatments for patients with lung adenocarcinoma.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10897198 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that contribute to the progression of lung adenocarcinoma, the most common type of lung cancer. It focuses on how specific transcription factors, such as NKX2-1 and HNF4α, interact to influence cell differentiation and plasticity in lung cancer cells. By examining these interactions, the research aims to uncover how certain cell states may promote tumor growth and progression. Patients may benefit from insights that could lead to new therapeutic strategies targeting these molecular pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lung adenocarcinoma, particularly those exhibiting mixed-lineage characteristics in their tumors.
Not a fit: Patients with other types of lung cancer or those without a diagnosis of lung adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the mechanisms driving lung adenocarcinoma progression.
How similar studies have performed: While the specific approach of investigating mixed-lineage states in lung adenocarcinoma is relatively novel, similar research has shown promise in understanding cancer plasticity and progression in other cancer types.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Fort, Gabriela M — University of Utah
- Study coordinator: Fort, Gabriela M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.